Therapeutic embolization of meningiomas with Onyx for delayed surgical resection

Surg Neurol. 2008 Nov;70(5):478-81. doi: 10.1016/j.surneu.2007.05.031. Epub 2008 Feb 8.


Background: Liquid embolic agents can achieve penetration of capillaries in tumors and thus may be even more effective at creating tumor necrosis than small particles. This study assesses the safety and efficacy of preoperative embolization of meningiomas with Onyx liquid embolic agent (Micro Therapeutics, Inc, Irvine, Calif) for delayed surgical resection.

Methods: Three cases of hypervascular intracranial meningiomas were treated by preoperative embolization with Onyx embolic agent using superselective catheterization of the feeding arteries from the ECA and the reflux-hold-reinjection technique.

Results: Meningiomas were devascularized successfully, and these patients did not present the symptoms of postembolization tumor swelling or hemorrhage before complete resection of the tumors 10 days later. Massive tumor necrosis was observed in all 3 cases of pathologic specimens, and shrinkage of tumor was seen by MRI as early as 8 days in 1 case. All patients had no recurrence of tumor at 12-month follow-up.

Conclusion: Preoperative embolization with Onyx may be a useful tool for treatment of meningiomas. Palliative embolization treatment of nonresectable hypervascular intracranial tumors with Onyx warrants future clinical investigation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Dimethyl Sulfoxide / therapeutic use*
  • Embolization, Therapeutic*
  • Female
  • Humans
  • Male
  • Meningeal Neoplasms / therapy*
  • Meningioma / therapy*
  • Middle Aged
  • Neoadjuvant Therapy
  • Polyvinyls / therapeutic use*


  • Onyx HD 500
  • Polyvinyls
  • Dimethyl Sulfoxide